Moors & Cabot Inc. Trims Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Moors & Cabot Inc. reduced its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 37,924 shares of the pharmacy operator’s stock after selling 3,375 shares during the period. Moors & Cabot Inc.’s holdings in Walgreens Boots Alliance were worth $354,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the stock. First Financial Corp IN boosted its position in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares during the period. Golden State Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at $26,000. Riverview Trust Co boosted its holdings in Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after buying an additional 1,590 shares during the period. Venturi Wealth Management LLC purchased a new stake in Walgreens Boots Alliance in the 4th quarter worth $28,000. Finally, TD Private Client Wealth LLC raised its holdings in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 3,208 shares during the period. 58.59% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their target price for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Royal Bank of Canada lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Finally, Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $11.54.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $11.23 on Friday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The company has a market cap of $9.70 billion, a PE ratio of -1.10, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The company’s 50 day moving average is $10.83 and its 200 day moving average is $9.76.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same period last year, the business earned $0.66 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 7.6% on a year-over-year basis. On average, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.